Voisard Asset Management Group »

Miragen Therapeutics shares owned by Voisard Asset Management Group

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Voisard Asset Management Group from 13F filings

Historical chart of Voisard Asset Management Group investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Voisard Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Voisard Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8k 100 17.51
2023-12-31 $2.2k 100 21.78

More positions owned by Voisard Asset Management Group

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Exch Trd Slf Idx Bulshs 2024 Cb (BSCO)

View all positions for Voisard Asset Management Group

Top funds holding Miragen Therapeutics

Paradigm Biocapital Advisors
VR Adviser
Vanguard Group
Maverick Capital
Alliancebernstein
Commodore Capital
Perceptive Advisors
Vivo Capital
Fairmount Funds Management
Yiheng Capital
Citadel Advisors
Tang Capital Management
Octagon Capital Advisors
Kynam Capital Management
Logos Global Management

View all funds holding Miragen Therapeutics